How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review of historical research and mechanistic concepts with no new empirical data or systematic search.
PubMed 34064393 · doi:10.3390/ijms22094861
What was done
This narrative review summarizes the historical research on prion diseases originating from scrapie in sheep and goats, and evaluates how principles of prion protein (PrP) misfolding, replication, and strain diversity inform the molecular pathogenesis of other neurodegenerative diseases. The authors compare PrP disorders to conditions involving misfolded amyloid-beta (Aβ), tau, and alpha-synuclein, arguing for the broader classification of these neurodegenerative conditions as prion diseases.
What was found
The abstract provides a qualitative, conceptual discussion and reports no numerical findings or effect estimates. It details how the paradigm of non-nucleic acid proteinaceous propagation discovered in scrapie and human prion diseases (such as Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker syndrome) parallels the molecular behavior of Aβ, tau, and alpha-synuclein in Alzheimer's disease, frontotemporal dementia, and Parkinson's disease.
Why it matters
Framing common neurodegenerative diseases through the lens of prion-like protein misfolding and spread helps unify pathogenic concepts across distinct disorders and informs target selection for disease-modifying therapies.
Limits
The paper is a non-systematic narrative review providing expert opinion and historical perspective rather than primary experimental, epidemiological, or clinical trial data. Broadening the definition of 'prion disease' to include non-transmissible neurodegenerative proteinopathies remains a conceptual framework that requires validation through clinical and therapeutic outcomes.
Cited by
- context Beta-amyloid is a prion, along with PrPSc and alpha-synuclein.